Studying Biomarkers and COPD Types in Chinese People
Part of Lungs & breathing clinical trials.
This study looks at signs (biomarkers) and different types of COPD in Chinese people. It aims to better understand COPD and pre-COPD, which may help with future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to do a breathing test correctly.
- You must not have asthma.
- You must not have had a COPD flare-up in the last 2 weeks.
- You must not have had lung surgery in the last 6 months.
- You must not have had cancer (other than certain skin cancers) in the last 5 years.
- You must not be pregnant if you are a woman.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at lung function in people with early COPD (chronic obstructive pulmonary disease) to understand what happens over time. If you meet the lung test and health requirements, you may be able to help researchers learn how to better track and manage early COPD.
This observational registry follows adults with COPD who are already being treated, to better understand real-world disease management and outcomes. You may benefit from structured follow-ups at the study site, but the study is not testing a new treatment.
This study tests a new portable device that measures how well your lungs work by having you breathe into a mouthpiece. Researchers want to see if this device can accurately identify different chronic lung conditions like COPD, asthma, bronchiectasis, and others.
This study compares simple breathing tests (oscillometry and FeNO) used by your primary care doctor against a specialist's diagnosis to see if they can accurately tell if you have asthma or COPD. If you have symptoms like wheezing, cough, or shortness of breath but haven't been diagnosed yet, this trial may help improve how these conditions are found.
This study looks at different lung immune cell patterns and how they work in smokers who are not yet diagnosed with COPD or asthma. It may help researchers understand why some people are more likely to develop COPD, which could guide future prevention or early treatments.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.